Soybeans as an Alternative to Hormone Replacement Therapy

References

• Greendale G A, Lee N P, Arriola E R. The menopause. Lancet 1999; 353(9152)571–580
   PubMed Web of Science ®Google Scholar
• Sylvia L. M. Physiology of menopause. US Pharmacist 1996 (Suppl). 1–15
   Google Scholar
• Pugh M C, Moynahan Mullins P. Hormone replacement therapy. Pharmacotherapy. A Pathophysiologic Approach. 4th ed, J T DiPiro, R L Talbert, GC Yee. Appleton & Lange, Stamford, CN 1999
   Google Scholar
• Thacker H. L. Women's Health. Menopause. Primary Care. Clin Office Pract 1997; 00(1)206–221
   Google Scholar
• McCowen Mehring P. Structure and function of the female reproductive system. Pathophysiology. Concepts of Altered Health States. 4th edition, C. M. Porth. Lippincott, New York, NY 1998
   Google Scholar
• Anderson E, Hamburger S, Liu J H, Rebar R W. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 1987; 156(2)428–33
   PubMed Web of Science ®Google Scholar
• Snow J. M. Everything You Need to Know About Menopause. Prima Publishing, Roseville, CA 1999
   Google Scholar
• Nachtigall L B, Nachtigall M J, Nachtigall L E. Nonprescription alternatives to hormone replacement therapy. Female Patient 1999; 24: 12–24
   Google Scholar
• Genazzani A R, Spinetti A, Gallo R, Bernardi F. Menopause and the central nervous system: intervention options. Maturitas 1999; 31(2)103–110
   PubMed Web of Science ®Google Scholar
• Gruenwald J. Standardized black cohosh (Cimicifuga) extract clinical monograph. Quarterly Rev Nat Med 1998; 117–125, (Summer)
   Google Scholar
• Taffe A M, Cauffield J. “Natural” hormone replacement therapy and dietary supplements used in the treatment of menopausal symptoms. Lippincotts Primary Care 1998; 2(3)292–302
   PubMedGoogle Scholar
• den Tonkelaar I, Oddens B J. Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol Apr, 2000; 95(4)507–12
   PubMed Web of Science ®Google Scholar
• Ringel M. Beyond hormones: other treatments for menopausal symptoms. Patient Care 1988; 28–30, 32, 37, 41–42, 44, 47–48, 51–52, 54, 59.
   Google Scholar
• Anderson J JB, Garner S C. Phytoestrogens and human function. Nutr Today 1997; 32(6)232–239
   Google Scholar
• Murkies A L, Wilcox G, Davis S R. Phytoestrogens. J Clin Endocrinology Me-tab 1998; 83(2)297–303
   PubMed Web of Science ®Google Scholar
• Hargreaves D F, Potten C S, Harding C, Shaw L E, Morton M S, Roberts S A, Howell A, Bundred N J. Two-week dietary soy supplementation has an estrogenic ef-16.fect on normal premenopausal breast. J Clin Endocrinol Metab 1999; 34(11)4017–4024
   Google Scholar
• Axelson M, Setchell K DR. The excretion of lignans in rats. Evidence for an intestinal bacterial source for this new group of compounds FEBS Lett 1981; 123: 337–342
   Google Scholar
• Grauds C. Soy monograph. Pharm Times Feb, 1999; 58–59
   Google Scholar
• Anderson J W, et al. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med 1995; 333(5)276–282
   PubMed Web of Science ®Google Scholar
• Anon., FDA Talk Paper. FDA approves new health claim for soy protein and coronary heart disease. http://vm.cfsan.fda.gov/~lrd/tpsoypr2.html. Accessed 11/05/1999.
   Google Scholar
• Potter S M, Baum J A, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women with low bone mass. Calcif Tissue Int 1994; 54: 377–380
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91(1)6–11
   PubMed Web of Science ®Google Scholar
• Bennetts H W, Underwood E J, Shier F L. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust Ve J 1946; 22: 2–12
   PubMedGoogle Scholar
• Tsourounis C, Dennehey C, Chavez M L, Miller B S. Natural medicines and women's health. The Rx Consultant 1999; 13(8)1–8
   Google Scholar
• Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990–994
   PubMed Web of Science ®Google Scholar
• Lee H P, Lourley L, Duffy S W, Esteve J, Lee J, Day N E. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197–1200
   PubMed Web of Science ®Google Scholar
• Nomura A, Henderson B E, Lee J. Breast cancer and diet among Japanese in Hawaii. Am J Clin Nutr 1978; 31: 2020–2025
   PubMed Web of Science ®Google Scholar
• Shimizu H, Ross R K, Bernstein L, Yatani R, Henderson B E, Nack T M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963–966
   PubMed Web of Science ®Google Scholar
• Ingram D, Sanders K, Kolybaba M, Lopez D. Case control study of phyto-oes-trogens and breast cancer. Lancet 1997; 350: 990–994
   PubMed Web of Science ®Google Scholar
• Wang W, Tanaka Y, Han Z, Higuchi C M. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer 1995; 23: 131–140
   PubMed Web of Science ®Google Scholar
• Santell R C, Chang Y C, Nair M G, Helferich W G. Dietary genistein exerts es-trogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 1997; 127: 263–269
   PubMed Web of Science ®Google Scholar
• Barnes S, Grubbs C, Setchell K DR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Biol Res 1990; 347: 239–253
   PubMedGoogle Scholar
• Barnes S, Peterson G, Coward L. Rationale for the use of genistein containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 1995; 22: 181–187
   Google Scholar
• Lamartiniere C A, Moore J, Holland M, Barnes S. Neonatal genistein chemo-prevents mammary cancer. Soc Exp Biol Med 1995; 208: 120–123
   PubMed Web of Science ®Google Scholar
• Hirano T, Oka K, Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumour cells of the human breast carcinoma cell line, ZR-75–1. Res Commun Chem Pathol Pharmacol 1989; 64: 69–77
   PubMedGoogle Scholar
• Paggliaci M C, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicolett I. Growth-inhibitory effects of natural phytoestrogen in MCF-7 human breast cancer cells. Eur J Cancer 1994; 30A: 1675–1682
   PubMed Web of Science ®Google Scholar
• Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991; 179: 661–667
   PubMed Web of Science ®Google Scholar
• Wang T TY, Sathyamoorthy N, Phang J M. Molecular effects of genistein on estrogen receptor (ER) mediated pathways. Carcinogenesis 1996; 17: 217–275
   Web of Science ®Google Scholar
• Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyro-sine-specific protein kinases. J Biol Chem 1987; 262: 5592–5595
   PubMed Web of Science ®Google Scholar
• Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Gensistein, a dietary derived inhibitor of in vitro angiogenesis. Pro Natl Acad Sci USA 1993; 90: 2690–2694
   PubMed Web of Science ®Google Scholar
• Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewica Z. Effects of geniste-nin on the growth and cell cycle progression of normal human lymphocytes and human leukaemic MOLT-4 m and HL-60 cells. Cancer Res 1992; 52: 6200–208
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Bannwart C, Wahala K T. Inhibition of human aromatase by mammalian lignans and isoflavonid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44(2)147–153
   PubMed Web of Science ®Google Scholar
• Campbell D R, Kurzer M S. Flavonoid inhibition of aromatase enzyme activity in human preadiopocyes. J Steroid Biochem Mol Biol 1993; 46: 381–388
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103(Suppl 7)103–11
   PubMed Web of Science ®Google Scholar
• Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of SHBG in Hep-GS human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 301–304
   PubMed Web of Science ®Google Scholar
• Wei H C, Wei L H, Frenkel K, Bowen R, Barnes S. Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 1993; 20: 1–12
   PubMed Web of Science ®Google Scholar
• Messina M. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113–131
   PubMed Web of Science ®Google Scholar
• Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Molec Biol 1993; 45: 399–405
   PubMed Web of Science ®Google Scholar
• Wang W, Tanaka Y, Han Z, Higuchi C M. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer 1995; 23: 131–140
   PubMed Web of Science ®Google Scholar
• Zava D T, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997; 27: 31–40
   PubMed Web of Science ®Google Scholar
• Land C. E. Studies of cancer radiation dose among atomic bomb survivors, the example of breast cancer. JAMA 1995; 274: 402–407
   PubMed Web of Science ®Google Scholar
• Clark R B, Howell A, Anderson E. Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 1997; 45: 121–133
   PubMed Web of Science ®Google Scholar